Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from PTAB

Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma

Big Tech is trying to discredit the PREVAIL Act by arguing that it'll lead to higher prescription drug costs. But new data debunks this myth.

Fortune

Big Tech's abuse of the patent system must end—take it from me, I've fought Google over IP for years

The bipartisan PREVAIL Act and RESTORE Patent Rights Act would make critical reforms to curb the abuse of the U.S. patent system by Big Tech.

Fortune

Intel Wins Appeal on VLSI Case, $2.18B Judgement Reversed

A U.S. appeals court on Monday overturned a 2021 patent infringement ruling against Intel that awarded patent holding company VLSI $2.18 billion over multiple patent violations. In a two-part decision, the court reversed a previous verdict that found that Intel violated a frequency management patent, while affirming the violation of…

AnandTech

From analysis to the latest developments in health,
read the most diverse news in one place.

Intel scores a rare win in multi-billion dollar rollercoaster lawsuit that'll make you say 'Is this really what patent law is like?'

Strap in, this is patent law at its most absurd.

PC Gamer

U.S. Patent Office Rules in Intel's Favor for $2.18 Billion VLSI Patents Case

U.S. PTO nullifies VLSI's 7,523,373 and 7,725,759 patents.

Tom’s Hardware

Cook County’s property tax system needs reform. Here’s how to fix it.

Accuracy in assessments, fair hiring, reforming the tax appeals process are some measures that must change, former Cook County Clerk David Orr writes.

Chicago Sun-Times

Mizuho Sees Relief For This Small-Cap Stock After Patent Legal Overhang Lifted

The US Patent Trial and Appeal Board (PTAB) issued a final written decision in favor of Concert Pharmaceuticals Inc (NASDAQ:CNCE) regarding the post-grant review (PGR) for the '659 method-of-use patent. The '659 patent claims methods of treating hair loss, including alopecia areata with certain doses of CTP-543, a deuterated form of ruxolitinib, JAK 1/2…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.